Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

Gastroenterology

Volumn 142, Issue 4, 2012, Pages

  Andersen, Jesper B ^a   Spee, Bart ^b   Blechacz, Boris R ^c   Avital, Itzhak ^a   Komuta, Mina ^b   Barbour, Andrew ^d   Conner, Elizabeth A ^a   Gillen, Matthew C ^a   Roskams, Tania ^b   Roberts, Lewis R ^c   Factor, Valentina M ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CCA; Gene Expression; Genetic Analysis; Hepatic

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; K RAS PROTEIN; KI 67 ANTIGEN; LAPATINIB; SCATTER FACTOR RECEPTOR; TRASTUZUMAB;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETICS; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 84859441690     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.12.005     Document Type: Article

References (32)

1. H.B. El-Serag, K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
2. M.L. DeOliveira, S.C. Cunningham, J.L. Cameron Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 2007 755 762
3. M.L. Deoliveira, R.D. Schulick, Y. Nimura New staging system and a registry for perihilar cholangiocarcinoma Hepatology 53 2011 1363 1371
4. M. Aljiffry, M.J. Walsh, M. Molinari Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 World J Gastroenterol 15 2009 4240 4262
5. B. Glimelius, K. Hoffman, P.O. Sjoden Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 7 1996 593 600
6. C. Bengala, F. Bertolini, N. Malavasi Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial Br J Cancer 102 2010 68 72
7. P.A. Philip, M.R. Mahoney, C. Allmer Phase II study of erlotinib in patients with advanced biliary cancer J Clin Oncol 24 2006 3069 3074
8. S.J. Lubner, M.R. Mahoney, J.L. Kolesar Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study J Clin Oncol 28 2010 3491 3497
9. D.G. Beer, S.L. Kardia, C.C. Huang Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat Med 8 2002 816 824
10. J.S. Lee, I.S. Chu, J. Heo Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
11. M.J. van de Vijver, Y.D. He, L.J. van't Veer A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
12. T. Harris Does large scale DNA sequencing of patient and tumor DNA yet provide clinically actionable information? Discov Med 10 2010 144 150
13. T. Harris Gene and drug matrix for personalized cancer therapy Nat Rev Drug Discov 9 2010 660
14. A. Subramanian, P. Tamayo, V.K. Mootha Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550
15. V.K. Mootha, C.M. Lindgren, K.F. Eriksson PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat Genet 34 2003 267 273
16. G. Finak, N. Bertos, F. Pepin Stromal gene expression predicts clinical outcome in breast cancer Nat Med 14 2008 518 527
17. B.R. Kipp, E.G. Barr Fritcher, A.C. Clayton Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography J Mol Diagn 12 2010 780 786
18. O. Nehls, M. Gregor, B. Klump Serum and bile markers for cholangiocarcinoma Semin Liver Dis 24 2004 139 154
19. A. Tannapfel, M. Benicke, A. Katalinic Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver Gut 47 2000 721 727
20. A.E. Sirica Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma World J Gastroenterol 14 2008 7033 7058
21. S.A. Kang, E.S. Lee, H.Y. Yoon PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1 J Biol Chem 285 2010 26013 26021
22. A. Villanueva, D.Y. Chiang, P. Newell Pivotal role of mTOR signaling in hepatocellular carcinoma Gastroenterology 135 2008 1972 1983 1983 e1-11
23. C.D. Briggs, C.P. Neal, C.D. Mann Prognostic molecular markers in cholangiocarcinoma: a systematic review Eur J Cancer 45 2009 33 47
24. H.G. Woo, J.H. Lee, J.H. Yoon Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 70 2010 3034 3041
25. J.L. Mott, G.J. Gores Targeting IL-6 in cholangiocarcinoma therapy Am J Gastroenterol 102 2007 2171 2172
26. S. Ohira, M. Sasaki, K. Harada Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma Am J Pathol 168 2006 1155 1168
27. J. Baselga, S.M. Swain Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nat Rev Cancer 9 2009 463 475
28. T.J. Lynch, D.W. Bell, R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
29. R. Rosell, T. Moran, C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 2009 958 967
30. G.Y. Gwak, J.H. Yoon, C.M. Shin Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas J Cancer Res Clin Oncol 131 2005 649 652
31. J.B. Andersen, V.M. Factor, J.U. Marquardt An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
32. H.G. Woo, J.H. Lee, J.H. Yoon Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 70 2010 3034 3041